BD PharmingenTM PE Mouse Anti-Human HLA-DR

Description

Flow cytometric analysis of HLA-DR on human peripheral blood lymphocytes. Human whole blood was lysed with BD FACS Lysing Solution Cat. No. 349202 and stained with PE Mouse IgG2a, kappa Isotype Control Cat. No. 555574; dashed line histogram or with PE Mouse Anti-Human HLA-DR Cat. No. 555812/560943; solid line histogram . Fluorescent histograms showing expression of HLA-DR or Ig isotype staining were derived from gated events based on forward and side light scattering characteristics for intact lymphocytes. Flow cytometric analysis was performed on a BD FACScan system. Flow cytometric analysis of HLA-DR on human peripheral blood lymphocytes. Human whole blood was lysed with BD FACS Lysing Solution Cat. No. 349202 and stained with PE Mouse IgG2a, kappa Isotype Control Cat. No. 555574; dashed line histogram or with PE Mouse Anti-Human HLA-DR Cat. No. 555812/560943; solid line histogram . Fluorescent histograms showing expression of HLA-DR or Ig isotype staining were derived from gated events based on forward and side light scattering characteristics for intact lymphocytes. Flow cytometric analysis was performed on a BD FACScan system. Show More Flow cytometric analysis of HLA-DR on human peripheral blood lymphocytes. Human whole blood was lysed with BD FACS Lysing Solution Cat. No. 349202 and stained with PE Mouse IgG2a, kappa Isotype Control Cat. No. 555574; dashed line histogram or with PE Mouse Anti-Human HLA-DR Cat. No. 555812/560943; solid line histogram . Fluorescent histograms showing expression of HLA-DR or Ig isotype staining were derived from gated events based on forward and side light scattering characteristics for intact lymphocytes. Flow cytometric analysis was performed on a BD FACScan system.